nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—KCNMA1—artery—uterine cancer	0.0338	0.0627	CbGeAlD
Hydroflumethiazide—ATP1A1—oviduct—uterine cancer	0.0328	0.0609	CbGeAlD
Hydroflumethiazide—KCNMA1—exocrine gland—uterine cancer	0.0295	0.0547	CbGeAlD
Hydroflumethiazide—ATP1A1—exocrine gland—uterine cancer	0.0189	0.0351	CbGeAlD
Hydroflumethiazide—CA7—renal system—uterine cancer	0.0175	0.0326	CbGeAlD
Hydroflumethiazide—SLC12A3—renal system—uterine cancer	0.0172	0.0319	CbGeAlD
Hydroflumethiazide—KCNMA1—myometrium—uterine cancer	0.0163	0.0303	CbGeAlD
Hydroflumethiazide—Jaundice cholestatic—Progesterone—uterine cancer	0.0151	0.0327	CcSEcCtD
Hydroflumethiazide—Glycosuria—Medroxyprogesterone Acetate—uterine cancer	0.0148	0.0322	CcSEcCtD
Hydroflumethiazide—CA2—exocrine gland—uterine cancer	0.0145	0.0269	CbGeAlD
Hydroflumethiazide—SLC12A1—epithelium—uterine cancer	0.0141	0.0263	CbGeAlD
Hydroflumethiazide—SLC12A3—female reproductive system—uterine cancer	0.0138	0.0255	CbGeAlD
Hydroflumethiazide—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.0137	0.0297	CcSEcCtD
Hydroflumethiazide—SLC12A1—renal system—uterine cancer	0.0131	0.0244	CbGeAlD
Hydroflumethiazide—KCNMA1—epithelium—uterine cancer	0.0128	0.0238	CbGeAlD
Hydroflumethiazide—KCNMA1—smooth muscle tissue—uterine cancer	0.0124	0.0229	CbGeAlD
Hydroflumethiazide—CA9—female reproductive system—uterine cancer	0.0123	0.0229	CbGeAlD
Hydroflumethiazide—KCNMA1—decidua—uterine cancer	0.0121	0.0225	CbGeAlD
Hydroflumethiazide—KCNMA1—renal system—uterine cancer	0.0119	0.0221	CbGeAlD
Hydroflumethiazide—CA12—renal system—uterine cancer	0.0114	0.0212	CbGeAlD
Hydroflumethiazide—Vascular purpura—Progesterone—uterine cancer	0.0108	0.0233	CcSEcCtD
Hydroflumethiazide—KCNMA1—uterus—uterine cancer	0.0106	0.0197	CbGeAlD
Hydroflumethiazide—ATP1A1—myometrium—uterine cancer	0.0105	0.0195	CbGeAlD
Hydroflumethiazide—Purpura—Progesterone—uterine cancer	0.00999	0.0217	CcSEcCtD
Hydroflumethiazide—CA5B—mammalian vulva—uterine cancer	0.00956	0.0177	CbGeAlD
Hydroflumethiazide—KCNMA1—female reproductive system—uterine cancer	0.00952	0.0177	CbGeAlD
Hydroflumethiazide—CA12—female reproductive system—uterine cancer	0.00913	0.0169	CbGeAlD
Hydroflumethiazide—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00905	0.0196	CcSEcCtD
Hydroflumethiazide—CA1—renal system—uterine cancer	0.00903	0.0168	CbGeAlD
Hydroflumethiazide—Aplastic anaemia—Dactinomycin—uterine cancer	0.0088	0.0191	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Progesterone—uterine cancer	0.00867	0.0188	CcSEcCtD
Hydroflumethiazide—ATP1A1—epithelium—uterine cancer	0.00824	0.0153	CbGeAlD
Hydroflumethiazide—CA5B—female reproductive system—uterine cancer	0.00819	0.0152	CbGeAlD
Hydroflumethiazide—ATP1A1—uterine cervix—uterine cancer	0.00817	0.0152	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00797	0.0173	CcSEcCtD
Hydroflumethiazide—ATP1A1—smooth muscle tissue—uterine cancer	0.00794	0.0147	CbGeAlD
Hydroflumethiazide—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00786	0.017	CcSEcCtD
Hydroflumethiazide—ATP1A1—decidua—uterine cancer	0.00778	0.0144	CbGeAlD
Hydroflumethiazide—ATP1A1—renal system—uterine cancer	0.00764	0.0142	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Progesterone—uterine cancer	0.00751	0.0163	CcSEcCtD
Hydroflumethiazide—CA5B—vagina—uterine cancer	0.00741	0.0137	CbGeAlD
Hydroflumethiazide—ATP1A1—endometrium—uterine cancer	0.00739	0.0137	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Etoposide—uterine cancer	0.00731	0.0159	CcSEcCtD
Hydroflumethiazide—CA1—female reproductive system—uterine cancer	0.00723	0.0134	CbGeAlD
Hydroflumethiazide—Jaundice—Progesterone—uterine cancer	0.00723	0.0157	CcSEcCtD
Hydroflumethiazide—ATP1A1—mammalian vulva—uterine cancer	0.00714	0.0133	CbGeAlD
Hydroflumethiazide—CA4—renal system—uterine cancer	0.00706	0.0131	CbGeAlD
Hydroflumethiazide—Blood uric acid increased—Etoposide—uterine cancer	0.00691	0.015	CcSEcCtD
Hydroflumethiazide—ATP1A1—uterus—uterine cancer	0.00681	0.0126	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.0068	0.0148	CcSEcCtD
Hydroflumethiazide—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00655	0.0142	CcSEcCtD
Hydroflumethiazide—CA2—epithelium—uterine cancer	0.00631	0.0117	CbGeAlD
Hydroflumethiazide—ATP1A1—female reproductive system—uterine cancer	0.00612	0.0114	CbGeAlD
Hydroflumethiazide—CA2—smooth muscle tissue—uterine cancer	0.00608	0.0113	CbGeAlD
Hydroflumethiazide—CA2—decidua—uterine cancer	0.00596	0.0111	CbGeAlD
Hydroflumethiazide—CA2—renal system—uterine cancer	0.00585	0.0109	CbGeAlD
Hydroflumethiazide—CA4—female reproductive system—uterine cancer	0.00565	0.0105	CbGeAlD
Hydroflumethiazide—Muscle spasms—Progesterone—uterine cancer	0.00557	0.0121	CcSEcCtD
Hydroflumethiazide—KCNMA1—lymph node—uterine cancer	0.00557	0.0103	CbGeAlD
Hydroflumethiazide—ATP1A1—female gonad—uterine cancer	0.00557	0.0103	CbGeAlD
Hydroflumethiazide—ATP1A1—vagina—uterine cancer	0.00553	0.0103	CbGeAlD
Hydroflumethiazide—CA2—mammalian vulva—uterine cancer	0.00547	0.0102	CbGeAlD
Hydroflumethiazide—Vertigo—Progesterone—uterine cancer	0.00521	0.0113	CcSEcCtD
Hydroflumethiazide—CA4—female gonad—uterine cancer	0.00514	0.00955	CbGeAlD
Hydroflumethiazide—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00505	0.011	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Dactinomycin—uterine cancer	0.00489	0.0106	CcSEcCtD
Hydroflumethiazide—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00483	0.0105	CcSEcCtD
Hydroflumethiazide—CA5B—lymph node—uterine cancer	0.00479	0.00889	CbGeAlD
Hydroflumethiazide—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00472	0.0102	CcSEcCtD
Hydroflumethiazide—Glycosuria—Epirubicin—uterine cancer	0.00469	0.0102	CcSEcCtD
Hydroflumethiazide—CA2—female reproductive system—uterine cancer	0.00469	0.0087	CbGeAlD
Hydroflumethiazide—Anorexia—Progesterone—uterine cancer	0.00451	0.00978	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Etoposide—uterine cancer	0.00444	0.00962	CcSEcCtD
Hydroflumethiazide—Glycosuria—Doxorubicin—uterine cancer	0.00434	0.00942	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Epirubicin—uterine cancer	0.00433	0.00939	CcSEcCtD
Hydroflumethiazide—CA2—female gonad—uterine cancer	0.00427	0.00791	CbGeAlD
Hydroflumethiazide—CA2—vagina—uterine cancer	0.00424	0.00787	CbGeAlD
Hydroflumethiazide—CA1—lymph node—uterine cancer	0.00423	0.00785	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.0042	0.00911	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Progesterone—uterine cancer	0.00411	0.00892	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Epirubicin—uterine cancer	0.0041	0.00889	CcSEcCtD
Hydroflumethiazide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00409	0.00887	CcSEcCtD
Hydroflumethiazide—Constipation—Progesterone—uterine cancer	0.00405	0.00878	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00401	0.00869	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Epirubicin—uterine cancer	0.00387	0.0084	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Doxorubicin—uterine cancer	0.00379	0.00823	CcSEcCtD
Hydroflumethiazide—Urticaria—Progesterone—uterine cancer	0.00376	0.00815	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00373	0.00809	CcSEcCtD
Hydroflumethiazide—Jaundice—Etoposide—uterine cancer	0.0037	0.00802	CcSEcCtD
Hydroflumethiazide—Leukopenia—Dactinomycin—uterine cancer	0.00367	0.00796	CcSEcCtD
Hydroflumethiazide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00367	0.00795	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Doxorubicin—uterine cancer	0.00358	0.00777	CcSEcCtD
Hydroflumethiazide—ATP1A1—lymph node—uterine cancer	0.00358	0.00664	CbGeAlD
Hydroflumethiazide—Aplastic anaemia—Epirubicin—uterine cancer	0.00357	0.00775	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Etoposide—uterine cancer	0.00354	0.00768	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Progesterone—uterine cancer	0.00349	0.00756	CcSEcCtD
Hydroflumethiazide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00341	0.00739	CcSEcCtD
Hydroflumethiazide—Asthenia—Progesterone—uterine cancer	0.0034	0.00736	CcSEcCtD
Hydroflumethiazide—CA4—lymph node—uterine cancer	0.00331	0.00614	CbGeAlD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—uterine cancer	0.0033	0.00717	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00327	0.0071	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Progesterone—uterine cancer	0.00324	0.00702	CcSEcCtD
Hydroflumethiazide—Anorexia—Dactinomycin—uterine cancer	0.00319	0.00692	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00316	0.00685	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Epirubicin—uterine cancer	0.00314	0.00682	CcSEcCtD
Hydroflumethiazide—Dizziness—Progesterone—uterine cancer	0.00313	0.00679	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Epirubicin—uterine cancer	0.00309	0.00669	CcSEcCtD
Hydroflumethiazide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00308	0.00667	CcSEcCtD
Hydroflumethiazide—Vomiting—Progesterone—uterine cancer	0.00301	0.00653	CcSEcCtD
Hydroflumethiazide—Rash—Progesterone—uterine cancer	0.00298	0.00647	CcSEcCtD
Hydroflumethiazide—Dermatitis—Progesterone—uterine cancer	0.00298	0.00647	CcSEcCtD
Hydroflumethiazide—Headache—Progesterone—uterine cancer	0.00296	0.00643	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00293	0.00636	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—uterine cancer	0.00291	0.00631	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Dactinomycin—uterine cancer	0.00291	0.00631	CcSEcCtD
Hydroflumethiazide—Purpura—Epirubicin—uterine cancer	0.00286	0.00621	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—uterine cancer	0.00286	0.00619	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Etoposide—uterine cancer	0.00285	0.00619	CcSEcCtD
Hydroflumethiazide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00615	CcSEcCtD
Hydroflumethiazide—Nausea—Progesterone—uterine cancer	0.00281	0.0061	CcSEcCtD
Hydroflumethiazide—CA2—lymph node—uterine cancer	0.00274	0.00509	CbGeAlD
Hydroflumethiazide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00591	CcSEcCtD
Hydroflumethiazide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.00586	CcSEcCtD
Hydroflumethiazide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.00586	CcSEcCtD
Hydroflumethiazide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.00583	CcSEcCtD
Hydroflumethiazide—Vertigo—Etoposide—uterine cancer	0.00267	0.00578	CcSEcCtD
Hydroflumethiazide—Leukopenia—Etoposide—uterine cancer	0.00266	0.00576	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—uterine cancer	0.00265	0.00575	CcSEcCtD
Hydroflumethiazide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.00552	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Epirubicin—uterine cancer	0.00252	0.00547	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Dactinomycin—uterine cancer	0.00246	0.00535	CcSEcCtD
Hydroflumethiazide—Asthenia—Dactinomycin—uterine cancer	0.0024	0.00521	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Etoposide—uterine cancer	0.00237	0.00514	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Epirubicin—uterine cancer	0.00234	0.00507	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00233	0.00506	CcSEcCtD
Hydroflumethiazide—Anorexia—Etoposide—uterine cancer	0.00231	0.00501	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Dactinomycin—uterine cancer	0.00229	0.00496	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Epirubicin—uterine cancer	0.00218	0.00472	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—uterine cancer	0.00216	0.0047	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Epirubicin—uterine cancer	0.00215	0.00467	CcSEcCtD
Hydroflumethiazide—Vomiting—Dactinomycin—uterine cancer	0.00213	0.00461	CcSEcCtD
Hydroflumethiazide—Rash—Dactinomycin—uterine cancer	0.00211	0.00457	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Etoposide—uterine cancer	0.0021	0.00456	CcSEcCtD
Hydroflumethiazide—Jaundice—Epirubicin—uterine cancer	0.00207	0.0045	CcSEcCtD
Hydroflumethiazide—Constipation—Etoposide—uterine cancer	0.00207	0.00449	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00202	0.00437	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—uterine cancer	0.00199	0.00432	CcSEcCtD
Hydroflumethiazide—Nausea—Dactinomycin—uterine cancer	0.00199	0.00431	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Epirubicin—uterine cancer	0.00199	0.00431	CcSEcCtD
Hydroflumethiazide—Urticaria—Etoposide—uterine cancer	0.00192	0.00417	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—uterine cancer	0.00192	0.00416	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—uterine cancer	0.00184	0.00398	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Etoposide—uterine cancer	0.00178	0.00387	CcSEcCtD
Hydroflumethiazide—Asthenia—Etoposide—uterine cancer	0.00174	0.00377	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Etoposide—uterine cancer	0.00166	0.00359	CcSEcCtD
Hydroflumethiazide—Dizziness—Etoposide—uterine cancer	0.0016	0.00347	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Epirubicin—uterine cancer	0.0016	0.00347	CcSEcCtD
Hydroflumethiazide—Vomiting—Etoposide—uterine cancer	0.00154	0.00334	CcSEcCtD
Hydroflumethiazide—Agitation—Epirubicin—uterine cancer	0.00153	0.00331	CcSEcCtD
Hydroflumethiazide—Rash—Etoposide—uterine cancer	0.00153	0.00331	CcSEcCtD
Hydroflumethiazide—Dermatitis—Etoposide—uterine cancer	0.00152	0.00331	CcSEcCtD
Hydroflumethiazide—Headache—Etoposide—uterine cancer	0.00152	0.00329	CcSEcCtD
Hydroflumethiazide—Vertigo—Epirubicin—uterine cancer	0.00149	0.00324	CcSEcCtD
Hydroflumethiazide—Leukopenia—Epirubicin—uterine cancer	0.00149	0.00323	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—uterine cancer	0.00148	0.00321	CcSEcCtD
Hydroflumethiazide—Nausea—Etoposide—uterine cancer	0.00144	0.00312	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—uterine cancer	0.00141	0.00307	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—uterine cancer	0.00138	0.003	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—uterine cancer	0.00138	0.00299	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Epirubicin—uterine cancer	0.00133	0.00288	CcSEcCtD
Hydroflumethiazide—Anorexia—Epirubicin—uterine cancer	0.00129	0.00281	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—uterine cancer	0.00123	0.00267	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—uterine cancer	0.0012	0.0026	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Epirubicin—uterine cancer	0.00118	0.00256	CcSEcCtD
Hydroflumethiazide—Constipation—Epirubicin—uterine cancer	0.00116	0.00252	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—uterine cancer	0.00109	0.00237	CcSEcCtD
Hydroflumethiazide—Urticaria—Epirubicin—uterine cancer	0.00108	0.00234	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—uterine cancer	0.00107	0.00233	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Epirubicin—uterine cancer	0.001	0.00217	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—uterine cancer	0.000997	0.00216	CcSEcCtD
Hydroflumethiazide—Asthenia—Epirubicin—uterine cancer	0.000974	0.00211	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Epirubicin—uterine cancer	0.000928	0.00201	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—uterine cancer	0.000925	0.00201	CcSEcCtD
Hydroflumethiazide—Asthenia—Doxorubicin—uterine cancer	0.000901	0.00195	CcSEcCtD
Hydroflumethiazide—Dizziness—Epirubicin—uterine cancer	0.000897	0.00195	CcSEcCtD
Hydroflumethiazide—Vomiting—Epirubicin—uterine cancer	0.000863	0.00187	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—uterine cancer	0.000859	0.00186	CcSEcCtD
Hydroflumethiazide—Rash—Epirubicin—uterine cancer	0.000856	0.00186	CcSEcCtD
Hydroflumethiazide—Dermatitis—Epirubicin—uterine cancer	0.000855	0.00185	CcSEcCtD
Hydroflumethiazide—Headache—Epirubicin—uterine cancer	0.00085	0.00184	CcSEcCtD
Hydroflumethiazide—Dizziness—Doxorubicin—uterine cancer	0.00083	0.0018	CcSEcCtD
Hydroflumethiazide—Nausea—Epirubicin—uterine cancer	0.000806	0.00175	CcSEcCtD
Hydroflumethiazide—Vomiting—Doxorubicin—uterine cancer	0.000798	0.00173	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—uterine cancer	0.000792	0.00172	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—uterine cancer	0.000791	0.00172	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—uterine cancer	0.000787	0.00171	CcSEcCtD
Hydroflumethiazide—Nausea—Doxorubicin—uterine cancer	0.000746	0.00162	CcSEcCtD
